GEODE CAPITAL MANAGEMENT, LLC - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 54 filers reported holding PYXIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$573,873
-7.7%
288,299
+18.7%
0.00%
Q2 2023$621,534
-35.2%
242,787
+1.4%
0.00%
Q1 2023$959,797
+351474.0%
239,351
+17.4%
0.00%
Q4 2022$273
-99.9%
203,934
+8.0%
0.00%
Q3 2022$371,000
+42.1%
188,821
+71.9%
0.00%
Q2 2022$261,000
-66.8%
109,847
-43.5%
0.00%
Q1 2022$786,000
-60.5%
194,577
+7.2%
0.00%
Q4 2021$1,990,000181,4720.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders